Login / Signup

Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.

Natsuki IshidaTakahiro MiyazuSatoshi TamuraShinya TaniMihoko YamadeMoriya IwaizumiYasushi HamayaSatoshi OsawaTakahisa FurutaKen Sugimoto
Published in: Digestive diseases and sciences (2021)
Tofacitinib is a promising therapeutic agent for the induction and maintenance therapy in UC. Baseline UCEIS may predict its therapeutic effects.
Keyphrases
  • ulcerative colitis
  • rheumatoid arthritis
  • stem cells
  • mesenchymal stem cells
  • smoking cessation